Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Sperm-associated antigen 7 (SPAG7) is a highly conserved, nuclear and cytoplasmic protein that contains an R3H domain predicted to bind polynucleotides such as single-stranded DNA or RNA. SPAG7 is primarily expressed in male germ cells, specifically during acrosome development of spermatids, and is also found in other tissues like muscle and nerve. It is believed to play a crucial role in sperm acrosome formation, tail structure, sperm motility, and male fertility. Deficiency of SPAG7 in animal models results in growth restriction, muscle atrophy, obesity, disrupted mitochondrial function in muscle, and significant reproductive deficits. Abnormal expression of SPAG7, and its regulation by specific microRNAs, is associated with male infertility, and alterations in its level are correlated with poor sperm count and motility. SPAG7 is not a classic therapeutic target such as a receptor or enzyme, but may serve as a biomarker for infertility and related disorders.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Sperm-associated antigen 7 (SPAG7).